Evaluation of Disinfecting Solutions and Protein Remover With a Silicone Hydrogel Lens
NCT ID: NCT00754338
Last Updated: 2023-09-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
76 participants
INTERVENTIONAL
2008-01-31
2008-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of an Investigational Multi-Purpose Disinfecting Solution
NCT01341977
Single Site Study of the Wettability of Contact Lenses With an Investigational Multi-Purpose Disinfecting Solution vs. a Marketed Multi-Purpose Solution
NCT00885092
Alcon Multi-Purpose Disinfecting Solution Versus Renu Fresh Multi-Purpose Solution in Symptomatic Contact Lens Wearers
NCT01187355
Multipurpose Disinfecting Solution Compatibility With a Silicone Hydrogel Contact Lens
NCT00520689
Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 2
NCT01684046
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Phase1 - Arm 1
Alcon Opti-Free® RepleniSH® with Supraclens®
Marketed Multipurpose Disinfecting Care System + Marketed contact lens protein remover
Alcon Opti-Free® RepleniSH®
Marketed Multipurpose Disinfecting Care System
Phase1 - Arm 2
Alcon Opti-Free® RepleniSH® with Supraclens®
Marketed Multipurpose Disinfecting Care System + Marketed contact lens protein remover
Alcon Opti-Free® RepleniSH®
Marketed Multipurpose Disinfecting Care System
Phase 2 - Arm 1
Alcon Opti-Free® RepleniSH® with Supraclens®
Marketed Multipurpose Disinfecting Care System + Marketed contact lens protein remover
B&L ReNu MultiPlus™
Marketed Multipurpose Disinfecting Care Systems
Phase 2 - Arm 2
Alcon Opti-Free® RepleniSH® with Supraclens®
Marketed Multipurpose Disinfecting Care System + Marketed contact lens protein remover
B&L ReNu MultiPlus™
Marketed Multipurpose Disinfecting Care Systems
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Alcon Opti-Free® RepleniSH® with Supraclens®
Marketed Multipurpose Disinfecting Care System + Marketed contact lens protein remover
Alcon Opti-Free® RepleniSH®
Marketed Multipurpose Disinfecting Care System
B&L ReNu MultiPlus™
Marketed Multipurpose Disinfecting Care Systems
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has read, understood and signed an information consent letter.
* Is willing and able to follow instructions and maintain the appointment schedule.
* Is correctable to a visual acuity of 6/9 or better (in each eye) with their habitual vision correction.
* Has clear corneas and no active ocular disease.
* Has had an ocular examination in the last two years.
* Is a current soft lens wearer, replacing their lenses every two weeks to one month.
* Has a distance contact lens prescription between +6.00D to -10.00 DS and can be successfully fit with the study lens.
* Has astigmatism less than or equal to -1.00 DC.
Exclusion Criteria
* Has any clinically significant blepharitis.
* Has undergone corneal refractive surgery.
* Is aphakic.
* Has any active ocular disease.
* Has any systemic disease affecting ocular health.
* Is using any systemic or topical medications that may affect ocular health.
* Has known sensitivity to the diagnostic pharmaceuticals to be used in the study.
* Is pregnant or lactating.
* Is participating in any other type of clinical or research study.
* Currently wears daily disposable lenses.
* Currently wears lenses on an extended wear basis.
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
University of Waterloo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Centre for Contact Lens Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Desmond Fonn, MOptom
Role: STUDY_CHAIR
University of Waterloo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre for Contact Lens Research, School of Optometry, University of Waterloo.
Waterloo, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P/279/07/L
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.